PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
29-Oct-2025 U.S. Hospitals Signal Pivot From Outsourced RCM to AI-Driven, On-Shore Operations as 2026 Progresses ACCESS Newswire
29-Oct-2025 Michael Jordan Game-Worn Memorabilia Headlines Infinite Auctions (Subsidiary of MDCE) Fall Flash Auction ACCESS Newswire
29-Oct-2025 Interactive Strength Inc. (NASDAQ:TRNR) Appoints Caleb Morgret as CFO To Drive the Transformation to Beyond $80m In Expected 2025 Pro Forma Revenue ACCESS Newswire
29-Oct-2025 Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date ACCESS Newswire
29-Oct-2025 Genesis Medical Detox Expands Into Kentucky, Bringing Compassionate, Medically Supervised Detox Services to Western Kentucky ACCESS Newswire
29-Oct-2025 Treating Measles Infection: Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive ACCESS Newswire
29-Oct-2025 Nomination Committee appointed ahead of the 2026 Annual General Meeting of iZafe Group AB ACCESS Newswire
29-Oct-2025 Imagene AI and Shaare Zedek Medical Center Form Strategic Data-AI Collaboration to Scale Oncology Research and Care ACCESS Newswire
29-Oct-2025 Dr. Mansher Singh Recognized Among America's Top Facelift Surgeons and Earns Triple Board Certification ACCESS Newswire
29-Oct-2025 Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome ACCESS Newswire
29-Oct-2025 Aspira Women's Health Wins Laboratory Service Contract with University of Texas Medical Branch at Galveston ACCESS Newswire
29-Oct-2025 Lex LasVegas to Emcee Compassion Center's Coalition for Patient Rights Inaugural Hoedown, Nov. 15 at Paradise Recreation Center ACCESS Newswire
29-Oct-2025 Santa Barbara City College Partners with Mentavi Health to Deliver Rapid, Clinically Validated ADHD Evaluations for Students ACCESS Newswire
29-Oct-2025 Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025 ACCESS Newswire
29-Oct-2025 Spago Nanomedical Resolves on a Rights Issue of Approximately SEK 25 million to Advance Tumorad ACCESS Newswire
29-Oct-2025 Senzime Q3 2025: Strong Growth and Clear Steps Towards Profitability ACCESS Newswire
29-Oct-2025 BioInvent International AB: Interim Report January - September 2025 ACCESS Newswire
29-Oct-2025 Spago Nanomedical Interim Report January-September 2025 ACCESS Newswire
29-Oct-2025 Hemogenyx Pharmaceuticals PLC Announces Clinical Trial Update and Grant of Share Awards ACCESS Newswire
29-Oct-2025 IRLAB Publishes Interim Report for The Period January - September 2025 ACCESS Newswire